Comerica Bank

Comerica Bank’s Vir Biotechnology VIR Stock Holding History

Comerica Bank’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$128K	Sell	21,238 -1,835	-8%	-$10.9K	﹤0.01%	2527
2025 Q3	$132K	Sell	23,073 -3,709	-14%	-$19K	﹤0.01%	2503
2025 Q2	$135K	Sell	26,782 -532	-2%	-$2.85K	﹤0.01%	2494
2025 Q1	$177K	Sell	27,314 -441	-2%	-$3.92K	﹤0.01%	2356
2024 Q4	$204K	Buy	27,755 +208	+0.8%	+$1.64K	﹤0.01%	2303
2024 Q3	$206K	Sell	27,547 -400	-1%	-$3.47K	﹤0.01%	2284
2024 Q2	$249K	Sell	27,947 -4,545	-14%	-$43.6K	﹤0.01%	2169
2024 Q1	$329K	Sell	32,492 -2,990	-8%	-$30.5K	﹤0.01%	2076
2023 Q4	$357K	Buy	35,482 +920	+3%	+$8.41K	﹤0.01%	2020
2023 Q3	$324K	Buy	+34,562	New	+$493K	﹤0.01%	1999
2022 Q4	$1.1M	Sell	42,035 -12,535	-23%	-$307K	0.01%	1388
2022 Q3	$1.19M	Sell	54,570 -5,405	-9%	-$137K	0.01%	1376
2022 Q2	$1.76M	Buy	+59,975	New	+$1.4M	0.01%	1186

Other funds holding VIR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return